BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30836373)

  • 1. Combination of Immunotherapy and Brain Radiotherapy in Metastatic Melanoma: A Retrospective Analysis.
    Galli G; Cavalieri S; Di Guardo L; Cimminiello C; Nichetti F; Corti F; Garcia MA; Pappalardi B; Fallai C; de Braud F; Platania M; Del Vecchio M
    Oncol Res Treat; 2019; 42(4):186-194. PubMed ID: 30836373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: Patterns of care and treatment outcomes.
    Gabani P; Fischer-Valuck BW; Johanns TM; Hernandez-Aya LF; Keller JW; Rich KM; Kim AH; Dunn GP; Robinson CG; Chicoine MR; Huang J; Abraham CD
    Radiother Oncol; 2018 Aug; 128(2):266-273. PubMed ID: 29960685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score.
    Schaule J; Kroeze SGC; Blanck O; Stera S; Kahl KH; Roeder F; Combs SE; Kaul D; Claes A; Schymalla MM; Adebahr S; Eckert F; Lohaus F; Abbasi-Senger N; Henke G; Szuecs M; Geier M; Sundahl N; Buergy D; Dummer R; Guckenberger M
    Radiat Oncol; 2020 Jun; 15(1):135. PubMed ID: 32487100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of timing of immunotherapy with cranial irradiation in melanoma patients with brain metastases: intracranial progression, survival and toxicity.
    Rahman R; Cortes A; Niemierko A; Oh KS; Flaherty KT; Lawrence DP; Sullivan RJ; Shih HA
    J Neurooncol; 2018 Jun; 138(2):299-306. PubMed ID: 29453679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival of patients after ipilimumab and hypofractionated brain radiotherapy for brain metastases of malignant melanoma: sequence matters.
    Schmidberger H; Rapp M; Ebersberger A; Hey-Koch S; Loquai C; Grabbe S; Mayer A
    Strahlenther Onkol; 2018 Dec; 194(12):1144-1151. PubMed ID: 30298365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant melanoma brain metastases: Treatment results and prognostic factors--a single-center retrospective study.
    Ostheimer C; Bormann C; Fiedler E; Marsch W; Vordermark D
    Int J Oncol; 2015; 46(6):2439-48. PubMed ID: 25891163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of targeted therapies and immunotherapy in melanoma brain metastases: A systematic review and meta-analysis.
    Rulli E; Legramandi L; Salvati L; Mandala M
    Cancer; 2019 Nov; 125(21):3776-3789. PubMed ID: 31287564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
    Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of extracranial radiation therapy in metastatic melanoma patients receiving immunotherapy.
    Gabani P; Robinson CG; Ansstas G; Johanns TM; Huang J
    Radiother Oncol; 2018 May; 127(2):310-317. PubMed ID: 29534829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery.
    Gaudy-Marqueste C; Dussouil AS; Carron R; Troin L; Malissen N; Loundou A; Monestier S; Mallet S; Richard MA; Régis JM; Grob JJ
    Eur J Cancer; 2017 Oct; 84():44-54. PubMed ID: 28783540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the Abscopal Effect With Anti-PD1 Therapy in Patients With Metastatic Solid Tumors.
    Ribeiro Gomes J; Schmerling RA; Haddad CK; Racy DJ; Ferrigno R; Gil E; Zanuncio P; Buzaid AC
    J Immunother; 2016; 39(9):367-372. PubMed ID: 27741091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy to Control Limited Melanoma Progression Following Ipilimumab.
    Kropp LM; De Los Santos JF; McKee SB; Conry RM
    J Immunother; 2016; 39(9):373-378. PubMed ID: 27662339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of radiation therapy as immune activator in the era of modern immunotherapy for metastatic malignant melanoma.
    Okwan-Duodu D; Pollack BP; Lawson D; Khan MK
    Am J Clin Oncol; 2015 Feb; 38(1):119-25. PubMed ID: 23648438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Innovations in Radiotherapy and Systemic Treatments With Clinical Outcomes in Patients With Melanoma Brain Metastasis From 2007 to 2016.
    Brastianos HC; Nguyen P; Sahgal A; Eisenhauer EA; Baetz T; Hanna TP
    JAMA Netw Open; 2020 Jul; 3(7):e208204. PubMed ID: 32663310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of patients with melanoma brain metastasis treated with stereotactic radiosurgery and active systemic drug therapies.
    Choong ES; Lo S; Drummond M; Fogarty GB; Menzies AM; Guminski A; Shivalingam B; Clarke K; Long GV; Hong AM
    Eur J Cancer; 2017 Apr; 75():169-178. PubMed ID: 28236768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS).
    Samlowski WE; Watson GA; Wang M; Rao G; Klimo P; Boucher K; Shrieve DC; Jensen RL
    Cancer; 2007 May; 109(9):1855-62. PubMed ID: 17351953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current concepts in advanced sinonasal mucosal melanoma: a single institution experience.
    Meerwein CM; Hüllner M; Braun R; Soyka MB; Morand GB; Holzmann D
    Eur Arch Otorhinolaryngol; 2019 Aug; 276(8):2259-2265. PubMed ID: 31098872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed Response to Immunotherapy in Patients with Metastatic Melanoma.
    Rauwerdink DJW; Molina G; Frederick DT; Sharova T; van der Hage J; Cohen S; Boland GM
    Ann Surg Oncol; 2020 Sep; 27(9):3488-3497. PubMed ID: 32472413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The changing paradigm of management in melanoma brain metastases.
    Ladwa R; Atkinson V
    Asia Pac J Clin Oncol; 2018 Dec; 14(6):453-458. PubMed ID: 29932306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.